Free Trial

Sumitomo Mitsui Trust Group Inc. Buys New Position in Cameco Corporation $CCJ

Cameco logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • Sumitomo Mitsui Trust Group bought 383,912 Cameco shares in the third quarter, worth about $33.3 million and representing roughly 0.09% of the company.
  • Institutional investors and hedge funds own 70.21% of Cameco; several major investors, including Bank of America, Canada Pension Plan Investment Board and BlackRock, also established positions.
  • Near-term pressures include a third-quarter earnings miss, lower uranium sales and a reduced 2026 outlook. Analysts’ consensus remains “Moderate Buy,” with a $147.38 average target price.
  • MarketBeat previews the top five stocks to own by December 1st.

Sumitomo Mitsui Trust Group Inc. purchased a new stake in Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 383,912 shares of the basic materials company's stock, valued at approximately $33,274,000. Sumitomo Mitsui Trust Group Inc. owned approximately 0.09% of Cameco at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Bank of America Corp DE bought a new position in Cameco during the 2nd quarter worth $735,498,000. Canada Pension Plan Investment Board acquired a new position in Cameco in the 2nd quarter valued at $420,346,000. BlackRock Inc. acquired a new position in Cameco in the 2nd quarter valued at $381,091,000. Cibc World Market Inc. bought a new stake in shares of Cameco during the 2nd quarter valued at $354,022,000. Finally, Amundi lifted its position in shares of Cameco by 13.7% during the 2nd quarter. Amundi now owns 2,992,074 shares of the basic materials company's stock valued at $304,773,000 after acquiring an additional 359,375 shares during the period. 70.21% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Cameco

Here are the key news stories impacting Cameco this week:

  • Positive Sentiment: Zacks Research upgraded Cameco from “strong sell” to “hold,” a modest improvement in its view of the stock. Tickerreport article
  • Positive Sentiment: On its earnings call, Cameco highlighted disciplined uranium pricing, tight nuclear-fuel supplies and potential growth from Westinghouse—factors that could support its longer-term outlook. The company also noted higher costs and weaker quarterly earnings. Cameco Q3 earnings call highlights
  • Neutral Sentiment: Cameco filed a technical report for its McArthur River operation. The filing provides operational information, but the report’s market impact is unclear from the available coverage. Cameco document filing
  • Negative Sentiment: Recent coverage cites a third-quarter earnings miss, lower uranium sales and a reduced 2026 outlook as near-term pressures on the shares. Cameco outlook after Q3 earnings
  • Negative Sentiment: Barclays cut its price target for Cameco, adding to cautious sentiment. The available report did not specify the revised target. Barclays price-target report

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CCJ. Zacks Research raised Cameco from a "strong sell" rating to a "hold" rating in a report on Tuesday. Weiss Ratings raised Cameco from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, October 8th. Jefferies Financial Group began coverage on shares of Cameco in a research report on Thursday, September 3rd. They set a "buy" rating and a $138.00 price objective for the company. Bank of America reduced their price objective on shares of Cameco from $143.00 to $140.00 and set a "buy" rating on the stock in a research note on Thursday, July 9th. Finally, Citigroup reiterated a "positive" rating on shares of Cameco in a research note on Wednesday, July 15th. Eleven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Cameco has a consensus rating of "Moderate Buy" and a consensus target price of $147.38.

Get Our Latest Stock Report on Cameco

Cameco Stock Down 4.6%

Shares of CCJ opened at $68.41 on Friday. The firm has a 50 day simple moving average of $87.96 and a two-hundred day simple moving average of $103.37. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.10. Cameco Corporation has a one year low of $66.06 and a one year high of $135.24. The company has a market cap of $29.79 billion, a P/E ratio of 103.65, a P/E/G ratio of 1.59 and a beta of 1.18.

Cameco Dividend Announcement

The firm also recently declared an annual dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 30th will be issued a dividend of C$0.24 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a dividend yield of 22.0%. Cameco's payout ratio is 24.24%.

Cameco Company Profile

(Free Report)

Cameco Corporation is a Canadian uranium company that explores for, mines, processes and supplies uranium used to generate nuclear power. The company produces uranium concentrates, commonly known as yellowcake, which are sold to nuclear utilities and other customers for conversion into nuclear fuel.

Cameco's principal mining operations are located in northern Saskatchewan, including the McArthur River and Cigar Lake mines. It also operates the Key Lake uranium mill and has interests in uranium assets in Kazakhstan through the Inkai joint venture.

Further Reading

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO.

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cameco Right Now?

Before you consider Cameco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.

While Cameco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines